Journal of cardiorespiratory research/Kardiorespirator tadqiqotlar jurnali 2-том 2-нөмір (2021)

ENERGY COVID-19 COLLAPSE: NEW DIAGNOSTIC MARKERS, TREATMENT ASPECTS

Саливончик Д.П, Саливончик Е.И

Дереккөзден оқу PDF

Аңдатпа

An independent diagnostic criterion for assessing the prognosis in patients with COVID-19 is the dynamics of lactate levels, the overproduction of which is due to the crisis of energy-producing systems and an overload of the glycolytic pathway of energy production. The only corrector for the energy collapse caused by COVID-19 is the use of thiotriazoline, a metabolic drug with multiple pathways for lactate utilization and stimulation of oxidative phosphorylation, with powerful antioxidant properties. Such drugs as blockers of fatty acid metabolism (trimetazidine, meldonium) in this situation have no pathogenetic and biochemical substantiation.

COVID-19, гиперпродукция лактата, энергетический коллапс, ТиотриазолинCOVID-19, lactate overproduction, energy collapse, thiotriazolineCOVID-19, laktatning ortiqcha ishlab chiqarilishi, energiya kollapsi, Tiotriazolin

Метадеректер дереккөзі: журналдың OAI-PMH архиві · Sindex толық мәтінді сақтамайды, дереккөзге сілтеме береді.

Дәйексөз алу

APA 7 
Саливончик Д.П & Саливончик Е.И (2021). ENERGY COVID-19 COLLAPSE: NEW DIAGNOSTIC MARKERS, TREATMENT ASPECTS. Journal of cardiorespiratory research/Kardiorespirator tadqiqotlar jurnali, 2(2).
GOST R 7.0.5 
Саливончик Д.П, Саливончик Е.И ENERGY COVID-19 COLLAPSE: NEW DIAGNOSTIC MARKERS, TREATMENT ASPECTS // Journal of cardiorespiratory research/Kardiorespirator tadqiqotlar jurnali. 2021. Т. 2. № 2.
BibTeX 
@article{д.п2021,
  author  = {Саливончик Д.П and Саливончик Е.И},
  title   = {ENERGY COVID-19 COLLAPSE: NEW DIAGNOSTIC MARKERS, TREATMENT ASPECTS},
  journal = {Journal of cardiorespiratory research/Kardiorespirator tadqiqotlar jurnali},
  year    = {2021},
  volume  = {2},
  number  = {2}
}
RIS 
TY  - JOUR
AU  - Саливончик Д.П
AU  - Саливончик Е.И
TI  - ENERGY COVID-19 COLLAPSE: NEW DIAGNOSTIC MARKERS, TREATMENT ASPECTS
JO  - Journal of cardiorespiratory research/Kardiorespirator tadqiqotlar jurnali
PY  - 2021
VL  - 2
IS  - 2
ER  -